Literature DB >> 17414055

Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer.

Han Na Kim1, Dong Wook Choi, Kyu Taek Lee, Jong Kyun Lee, Jin Seok Heo, Seong-Ho Choi, Seung Woon Paik, Jong Chul Rhee, Anson W Lowe.   

Abstract

OBJECTIVES: The purpose of this study was to screen for genes related to lymph node metastasis by comparing the differences in the expression profile between pancreatic cancer with lymph node metastasis and one without, and to predict the invasiveness and the progression of pancreatic cancer on the basis of these findings.
METHODS: The total RNA of the tissues was extracted from 10 pancreatic cancer specimens, including those with lymph node metastasis and those with no metastasis. It was studied by means of a DNA microarray (oligo chip) consisting of 37,842 genes. We screened out 1.5-fold or more differential gene expressions in at least 5 pairs of samples. We classified both samples and genes using a 2-way clustering analysis. The screened-out genes were identified using real-time polymerase chain reaction.
RESULTS: We identified 194 genes, including 66 overexpressed and 128 underexpressed genes, in pancreatic cancer with lymph node metastasis. Among them, we identified some genes related to lymph node metastasis in patients with pancreatic cancer: oncogenes, tumor suppressor genes, apoptosis and antiapoptosis genes, tumor angiogenesis factors, and cell cycle regulators. Genes promoting the growth of tumor cells were highly expressed in lymph node-positive pancreatic cancer, whereas genes inducing apoptosis were underexpressed.
CONCLUSIONS: We have identified genes that may play an important role in metastasis and survival in patients with pancreatic cancer. These results provide new insight into the study of human pancreatic cancer metastasis, including lymph node metastasis, and ultimately may lead to improving early diagnosis and discovering innovative therapeutic approaches for cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414055     DOI: 10.1097/MPA.0b013e3180317b01

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  13 in total

1.  Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer.

Authors:  Ji-Han Jung; Hye-Jung Kim; Jeonghun Yeom; Changyoung Yoo; Jihye Shin; Jinyoung Yoo; Chang Suk Kang; Cheolju Lee
Journal:  J Gastroenterol       Date:  2011-10-21       Impact factor: 7.527

2.  Gene expression profiles associated with advanced pancreatic cancer.

Authors:  Domenico Campagna; Leslie Cope; Sindhu S Lakkur; Clark Henderson; Daniel Laheru; Christine A Iacobuzio-Donahue
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Study of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis.

Authors:  Sinem Nalbantoglu; Mones Abu-Asab; Ming Tan; Xuemin Zhang; Ling Cai; Hakima Amri
Journal:  OMICS       Date:  2016-07

4.  A gene expression classifier of node-positive colorectal cancer.

Authors:  Paul F Meeh; Christopher L Farrell; Randal Croshaw; Hampton Crimm; Samantha K Miller; Dora Oroian; Sangeeta Kowli; Jinyu Zhu; Wayne Carver; Wensong Wu; Edsel Pena; Phillip J Buckhaults
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

5.  A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.

Authors:  Jeran K Stratford; David J Bentrem; Judy M Anderson; Cheng Fan; Keith A Volmar; J S Marron; Elizabeth D Routh; Laura S Caskey; Jonathan C Samuel; Channing J Der; Leigh B Thorne; Benjamin F Calvo; Hong Jin Kim; Mark S Talamonti; Christine A Iacobuzio-Donahue; Michael A Hollingsworth; Charles M Perou; Jen Jen Yeh
Journal:  PLoS Med       Date:  2010-07-13       Impact factor: 11.069

6.  DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.

Authors:  Geng Zhang; Aaron Schetter; Peijun He; Naotake Funamizu; Jochen Gaedcke; B Michael Ghadimi; Thomas Ried; Raffit Hassan; Harris G Yfantis; Dong H Lee; Curtis Lacy; Anirban Maitra; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

7.  A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.

Authors:  Timothy E Newhook; Edik M Blais; James M Lindberg; Sara J Adair; Wenjun Xin; Jae K Lee; Jason A Papin; J Thomas Parsons; Todd W Bauer
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

8.  Molecular markers associated with outcome and metastasis in human pancreatic cancer.

Authors:  Anke Van den Broeck; Hugo Vankelecom; Rudy Van Eijsden; Olivier Govaere; Baki Topal
Journal:  J Exp Clin Cancer Res       Date:  2012-08-27

Review 9.  Molecular mechanism underlying lymphatic metastasis in pancreatic cancer.

Authors:  Zhiwen Xiao; Guopei Luo; Chen Liu; Chuntao Wu; Liang Liu; Zuqiang Liu; Quanxing Ni; Jiang Long; Xianjun Yu
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

10.  Pro-oncogenic function of HIP-55/Drebrin-like (DBNL) through Ser269/Thr291-phospho-sensor motifs.

Authors:  Zijian Li; Hae Ryon Park; Zhi Shi; Zenggang Li; Cau Dinh Pham; Yuhong Du; Fadlo R Khuri; Youyi Zhang; Qide Han; Haian Fu
Journal:  Oncotarget       Date:  2014-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.